senate Bill S1737

2021-2022 Legislative Session

Relates to creating a wholesale prescription drug importation program

download bill text pdf

Sponsored By

Current Bill Status - Passed Senate


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (8)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
May 24, 2022 referred to higher education
delivered to assembly
passed senate
May 23, 2022 ordered to third reading cal.1421
May 17, 2022 reported and committed to rules
May 11, 2022 reported and committed to finance
Jan 05, 2022 referred to health
Jan 14, 2021 referred to health

Votes

view votes

May 23, 2022 - Rules committee Vote

S1737
15
1
committee
15
Aye
1
Nay
5
Aye with Reservations
0
Absent
0
Excused
0
Abstained
show Rules committee vote details

May 17, 2022 - Finance committee Vote

S1737
16
2
committee
16
Aye
2
Nay
4
Aye with Reservations
1
Absent
0
Excused
0
Abstained
show Finance committee vote details

May 9, 2022 - Health committee Vote

S1737
10
3
committee
10
Aye
3
Nay
1
Aye with Reservations
0
Absent
1
Excused
0
Abstained
show Health committee vote details

Health Committee Vote: May 9, 2022

aye wr (1)
excused (1)

Co-Sponsors

view additional co-sponsors

S1737 (ACTIVE) - Details

See Assembly Version of this Bill:
A133
Current Committee:
Assembly Higher Education
Law Section:
Public Health Law
Laws Affected:
Add Art 2-A Title 2 §280-d, Pub Health L
Versions Introduced in 2019-2020 Legislative Session:
S5682, A7588

S1737 (ACTIVE) - Summary

Creates a wholesale prescription drug importation program which complies with federal standards and regulations for the purpose of generating substantial savings for consumers.

S1737 (ACTIVE) - Sponsor Memo

S1737 (ACTIVE) - Bill Text download pdf

 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   1737
 
                        2021-2022 Regular Sessions
 
                             I N  S E N A T E
 
                             January 14, 2021
                                ___________
 
 Introduced  by  Sens. SKOUFIS, BENJAMIN, BIAGGI, FELDER, GAUGHRAN, HOYL-
   MAN, JACKSON, MAY, MYRIE, THOMAS -- read twice  and  ordered  printed,
   and when printed to be committed to the Committee on Health
 
 AN  ACT to amend the public health law, in relation to creating a whole-
   sale prescription drug importation program

   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1. Title 2 of article 2-A of the public health law is amended
 by adding a new section 280-d to read as follows:
   § 280-D. WHOLESALE PRESCRIPTION DRUG  IMPORTATION  PROGRAM.    1.  (A)
 THERE  IS HEREBY CREATED IN THE DEPARTMENT A WHOLESALE PRESCRIPTION DRUG
 IMPORTATION PROGRAM.
   (B) AS USED IN THIS  SECTION,  UNLESS  THE  CONTEXT  CLEARLY  REQUIRES
 OTHERWISE, THE FOLLOWING TERMS SHALL HAVE THE FOLLOWING MEANINGS:
   (I)  "WHOLESALE  PRESCRIPTION  DRUG  IMPORTATION PROGRAM" OR "PROGRAM"
 MEANS THE WHOLESALE PRESCRIPTION DRUG IMPORTATION PROGRAM CREATED  UNDER
 THIS SECTION.
   (II)  "PRESCRIPTION  DRUG  WHOLESALER"  MEANS  AN ENTITY AUTHORIZED TO
 ACQUIRE PRESCRIPTION DRUGS AND SELL OR DISTRIBUTE THEM WHOLESALE IN  THE
 STATE.
   (III)  "APPROVED  WHOLESALER"  MEANS  A  PRESCRIPTION  DRUG WHOLESALER
 APPROVED UNDER THIS SECTION TO PARTICIPATE IN THE PROGRAM.
   (C) THE COMMISSIONER  SHALL  DEVELOP  AND  IMPLEMENT  THE  PROGRAM  IN
 CONSULTATION  WITH INTERESTED STAKEHOLDERS AND APPROPRIATE FEDERAL OFFI-
 CIALS. THE PROGRAM SHALL COMPLY WITH  APPLICABLE  FEDERAL  REQUIREMENTS,
 INCLUDING  21  U.S.C.  § 384, AND REQUIREMENTS REGARDING SAFETY AND COST
 SAVINGS. UNDER THE PROGRAM:
   (I) THE COMMISSIONER SHALL  APPROVE  ONE  OR  MORE  PRESCRIPTION  DRUG
 WHOLESALERS  TO  SEEK  FEDERAL  CERTIFICATION  AND  APPROVAL  TO  IMPORT
 PRESCRIPTION DRUGS FROM ONE OR MORE  OTHER  COUNTRIES,  TO  BE  SOLD  OR
 DISTRIBUTED WHOLESALE IN THE STATE;
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.